Reprint

Recent Advances in Antibody Therapeutics

Edited by
June 2022
238 pages
  • ISBN978-3-0365-4353-6 (Hardback)
  • ISBN978-3-0365-4354-3 (PDF)

This book is a reprint of the Special Issue Recent Advances in Antibody Therapeutics that was published in

Biology & Life Sciences
Chemistry & Materials Science
Medicine & Pharmacology
Summary

Since first receiving approval in 1986, antibody-based therapeutics have been the most successful modality for the treatment of various diseases. This Special Issue of IJMS, “Recent Advances in Antibody Therapeutics”, presents leading-edge articles and reviews for discovery, development, and clinical applications of therapeutic antibodies, covering antibody drug conjugates (ADCs), GPCR-targeting antibodies, a functional antibody screening, bioassay of bispecific antibodies, antibody applications for cardiovascular diseases, antibody delivery to CNS, etc. The excellent studies in this Special Issue would valuable insight for scientists and clinicians in the field of therapeutic antibodies

 

Format
  • Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
interleukin 33; ST2 receptor; scFv; C2_2E12; bladder cancer; antibodies; immune checkpoint inhibitors; antibody-drug conjugates; sacituzumab govitecan; enfortumab vedotin; erdafitinib; cost-effectiveness; G protein-coupled receptor; membrane protein; antigen; therapeutic antibody; anti-angiogenesis; delta-like ligand; irinotecan; paclitaxel; therapeutic antibody; VEGF; SARS-CoV-2; spike protein; receptor-binding domain; phage display; monoclonal antibody; cytomegalovirus; peptide/major histocompatibility complex class I complex; T-cell-receptor-like antibody; affinity maturation; yeast surface display; combinatorial antibody library; agonist antibody; cell fate; phage display; bispecific antibodies; bioassays; mechanisms of action; binding assays; potency assays; atherosclerosis; inflammation; antibody therapy; blood–brain barrier; antibody; pharmacokinetics; disposition; biochemical and physicochemical properties; Fc binding; receptor-mediated transcytosis; brain shuttle; molecular Trojan horse; transferrin; therapeutic antibody; anti-cancer antibody; antibody engineering; biophysical properties; computational methods; research cell bank; antibody therapeutics; recombinant antibodies; intracellular antibodies; single-chain antibody fragment; nanobody; Human papillomaviruses; HPV oncoproteins; HPV-associated cancer; HPV cancer therapy; asthma; refractory asthma; antibody therapeutics; biomarker; n/a